T-Cell Therapy Puts Leukemia Patients in Extended Remission

October 16, 2014

(New York Times) – An experimental therapy has brought prolonged remissions to a high proportion of patients who were facing death from advanced leukemia after standard treatments had failed, researchers are reporting. The therapy involves genetically programming cells from the patient’s own immune system to fight the disease. The research included 30 patients: five adults ages 26 to 60, and 25 children and young adults ages 5 to 22.